SHELDON SLOAN

Track

Insider profile

SHELDON SLOAN's trades of Spyre Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01
PlS Planned sale
94,738 +47.6%
65.02
US$4,267,317 		94,738 +47.6% 65.02 US$4,267,317
2026-07-02 2026-07-01
PlS Planned sale
91,060 +4.5%
136.64
US$384,525 		91,060 +4.5% 136.64 US$384,525
2026-06-03 2026-06-03
PlS Planned sale
89,222 -48.5%
473.15
US$2,225,032 		89,222 -48.5% 473.15 US$2,225,032
2026-06-03 2026-06-03
PrS Proposed sale
16,667
69.16
US$1,152,690 		16,667 69.16 US$1,152,690
2026-05-01 2026-05-01
PlS Planned sale
400 -100.0%
75.37
US$30,148 		400 -100.0% 75.37 US$30,148
2026-05-01 2026-05-01
PlS Planned sale
5,059 -92.7%
74.60
US$377,401 		5,059 -92.7% 74.60 US$377,401
2026-05-01 2026-05-01
PlS Planned sale
10,358 -65.5%
73.74
US$763,799 		10,358 -65.5% 73.74 US$763,799
2026-05-01 2026-05-01
PlS Planned sale
12,777 -44.7%
72.94
US$931,954 		12,777 -44.7% 72.94 US$931,954
2026-05-01 2026-05-01
PlS Planned sale
8,777 -23.5%
71.56
US$628,082 		8,777 -23.5% 71.56 US$628,082
2026-05-01 2026-05-01
PlS Planned sale
19,656 -34.5%
70.61
US$1,387,910 		19,656 -34.5% 70.61 US$1,387,910
2026-05-01 2026-05-01
PlS Planned sale
21,306 -27.2%
69.53
US$1,481,406 		21,306 -27.2% 69.53 US$1,481,406
2026-05-01 2026-05-01
PrS Proposed sale
78,333
74.45
US$5,831,892 		78,333 74.45 US$5,831,892
2026-04-03 2026-04-01
PlS Planned sale
7,958 -100.0%
50.00
US$397,900 		7,958 -100.0% 50.00 US$397,900
2026-04-01 2026-04-01
PrS Proposed sale
7,958
50.44
US$401,402 		7,958 50.44 US$401,402